|
Volumn 49, Issue 3, 2002, Pages 187-193
|
Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells
a a a a |
Author keywords
Breast cancer; Cell culture; Enoyl reductase; Enzyme inhibition; Fatty acid synthase; Triclosan
|
Indexed keywords
ENOYL REDUCTASE;
FATTY ACID SYNTHASE;
OXIDOREDUCTASE;
TRICLOSAN;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
BINDING ASSAY;
BREAST CARCINOMA;
CANCER CELL CULTURE;
CANCER CHEMOTHERAPY;
CANCER INHIBITION;
CELL STRAIN MCF 7;
CELL VIABILITY;
COMPETITIVE INHIBITION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG ACTIVITY;
DRUG BINDING;
DRUG EFFECT;
DRUG POTENCY;
DRUG TARGETING;
ENZYME ACTIVITY;
ENZYME INHIBITION;
GOOSE;
HUMAN;
HUMAN CELL;
IC 50;
IN VITRO STUDY;
NONHUMAN;
PRIORITY JOURNAL;
SPECTROPHOTOMETRY;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CELL SURVIVAL;
ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH);
FATTY ACID SYNTHETASE COMPLEX;
FEMALE;
HUMANS;
KINETICS;
OXIDOREDUCTASES;
TRICLOSAN;
TUMOR CELLS, CULTURED;
|
EID: 0036185911
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s00280-001-0399-x Document Type: Article |
Times cited : (103)
|
References (33)
|